| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1440-1614.2004.01356.X |
| P2860 | cites work | Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 |
| Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders | Q28269677 | ||
| The pharmacological treatment of delusional depression | Q28306166 | ||
| Depressogenic cognitive styles: predictive validity, information processing and personality characteristics, and developmental origins | Q33662267 | ||
| Systematic overview of lithium treatment in acute mania | Q33905283 | ||
| Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
| A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders | Q33927263 | ||
| Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression | Q33949128 | ||
| Clinical features and management of lithium poisoning | Q34049436 | ||
| Bipolar depression: pharmacotherapy and related therapeutic strategies | Q34052825 | ||
| Neuroplasticity and cellular resilience in mood disorders | Q34111006 | ||
| Lithium Response in Unipolar Versus Bipolar Depression | Q34212310 | ||
| Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study | Q34221866 | ||
| 'Why getting fat, Doc?' Weight gain and psychotropic medications. | Q34299393 | ||
| Serum lithium levels and psychosocial function in patients with bipolar I disorder | Q34399711 | ||
| Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group | Q34514128 | ||
| A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year | Q34531152 | ||
| Valproate in the treatment of acute mania. A placebo-controlled study | Q34613045 | ||
| Schema-focused cognitive therapy for bipolar disorder: reducing vulnerability to relapse through attitudinal change | Q35048179 | ||
| Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder | Q37152810 | ||
| Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment | Q37402290 | ||
| Alternatives to lithium for preventive treatment of bipolar disorder | Q38355138 | ||
| Lithium prophylaxis: myths and realities | Q38623725 | ||
| Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression | Q39410022 | ||
| Patient Selection for Long-term Lithium Treatment in Clinical Practice | Q39669307 | ||
| Can antidepressants cause mania and worsen the course of affective illness? | Q39677054 | ||
| Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy | Q40744586 | ||
| Forty years of lithium treatment | Q40915654 | ||
| The place of anticonvulsant therapy in bipolar illness | Q41257728 | ||
| Alternative approaches to refractory depression in bipolar illness | Q41617344 | ||
| Patient and physician attitudes toward lithium: relationship to compliance | Q41666337 | ||
| Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history | Q41777076 | ||
| Lithium treatment of depression | Q42235773 | ||
| Mixed mania: apparent induction by a tricyclic antidepressant in five consecutively treated patients with bipolar depression | Q42281346 | ||
| Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial | Q42625897 | ||
| A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
| Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 | ||
| Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients | Q43540822 | ||
| ECT in bipolar and unipolar depression: differences in speed of response | Q43595309 | ||
| Efficacy of lithium as acute treatment of manic-depressive illness | Q43647019 | ||
| Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy | Q43846648 | ||
| Olanzapine versus divalproex in the treatment of acute mania | Q44013092 | ||
| Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 | ||
| The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression | Q44674218 | ||
| Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study | Q44675680 | ||
| A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania | Q44684784 | ||
| A double-blind comparison of valproate and lithium in the treatment of acute mania | Q44975667 | ||
| Tranylcypromine versus imipramine in anergic bipolar depression | Q45000348 | ||
| Psychoeducation of partners of bipolar-manic patients | Q49170246 | ||
| The enduring psychosocial consequences of mania and depression. | Q50608957 | ||
| Depression during mania. Treatment response to lithium or divalproex. | Q50978467 | ||
| Group cognitive behavioral therapy for bipolar disorder: a feasibility and effectiveness study. | Q51066517 | ||
| Methodological considerations for the development of new treatments for bipolar disorder. | Q51083721 | ||
| Expressed emotion and interactional patterns in the families of bipolar patients. | Q51095029 | ||
| A consumer perspective concerning the diagnosis and treatment of bipolar disorder. | Q51973354 | ||
| Comorbidity in mania at first hospitalization | Q52044700 | ||
| The epidemiology of DSM-III-R bipolar I disorder in a general population survey. | Q53357821 | ||
| Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. | Q53884881 | ||
| Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. | Q53965654 | ||
| Medication resistance and clinical response to electroconvulsive therapy. | Q54329990 | ||
| Clinical and Serum-Level Monitoring in Lithium Therapy and Lithium Intoxication | Q55893602 | ||
| A reevaluation of risk of in utero exposure to lithium | Q57386813 | ||
| A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission | Q57612892 | ||
| Cognitive Therapy for Bipolar Illness—A Pilot Study of Relapse Prevention | Q58430030 | ||
| P433 | issue | 5 | |
| P921 | main subject | New Zealand | Q664 |
| bipolar disorder | Q131755 | ||
| P304 | page(s) | 280-305 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Australian and New Zealand Journal of Psychiatry | Q4824838 |
| P1476 | title | Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder | |
| P478 | volume | 38 |
| Q35787071 | A qualitative analysis of relatives', health professionals' and service users' views on the involvement in care of relatives in Bipolar Disorder |
| Q51904096 | Application of the Cockcroft-Gault method to estimate lithium dosage requirement. |
| Q37703227 | Bipolar disorder in young people: Description, assessment and evidence-based treatment. |
| Q36161335 | Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies |
| Q38904156 | Do current national and international guidelines have specific recommendations for older adults with bipolar disorder? A brief report |
| Q37632540 | Managing depression across the life cycle: new strategies for clinicians and their patients. |
| Q26797449 | Mobile Apps for Bipolar Disorder: A Systematic Review of Features and Content Quality |
| Q47339854 | Prospective study of risk factors for attempted suicide among patients with bipolar disorder |
| Q37871060 | Psychological needs of adolescents in the early phase of bipolar disorder: implications for early intervention |
| Q34616633 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression |
| Q34550618 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment |
| Q34606256 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania |
| Q38040453 | The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states? |
| Q42823628 | The king is dead, long live the king! The restoration of BALANCE |
| Q36106769 | Treatment of bipolar depression: focus on pharmacologic therapies |
| Q36681343 | Zonisamide for bipolar depression |
Search more.